The influence of vitamin C on systemic markers of endothelial and inflammatory cell activation in smokers and non-smokers

Inflammation Research

Volumn 54, Issue 3, 2005, Pages 138-144

  Scott, D A ^a   Poston, R N ^b   Wilson, R F ^b   Coward, P Y ^b   Palmer, R M ^b  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cotinine; Elastase; ICAM 1; Neopterin; Tobacco smoking

Indexed keywords

ASCORBIC ACID; COTININE; INTERCELLULAR ADHESION MOLECULE 1; LEUKOCYTE ELASTASE; NEOPTERIN; PLACEBO;

ADULT; ARTICLE; CELL ACTIVATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVITY; FEMALE; HOSPITAL; HUMAN; INFLAMMATORY CELL; LEUKOCYTE ACTIVATION; MALE; MONOCYTE; RANDOMIZED CONTROLLED TRIAL; SMOKING HABIT; VITAMIN SUPPLEMENTATION;

ADULT; ANTIOXIDANTS; ASCORBIC ACID; BIOLOGICAL MARKERS; COTININE; ENDOTHELIUM; FEMALE; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; LEUKOCYTE ELASTASE; LUNG; MALE; MIDDLE AGED; NEOPTERIN; PLACEBOS; SMOKING; TIME FACTORS;

EID: 20044383622     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-004-1335-4     Document Type: Article

References (70)

1. Anderson R. Assessment of the roles of vitamin C, vitamin E, and beta-carotene in the modulation of oxidant stress mediated by cigarette smoke-activated phagocytes. Am J Clin Nutr 1991; 53: 358S-61S.
2. Barbour SE, Nakashima K, Zhang JB, Tangada S, Hahn CL, Schenkein HA et al. Tobacco and smoking: environmental factors that modify the host response (immune system) and have an impact on periodontal health. Crit Rev Oral Biol Med 1997; 8: 437-60.
3. Cooke JP, Bitterman H. Nicotine and angiogenesis: a new paradigm for tobacco-related diseases. Ann Med 2004; 36: 33-40.
4. van der Vaart H, Postma DS, Timens W, ten Hacken NH. Acute effects of cigarette smoke on inflammation and oxidative stress: a review. Thorax 2004; 59: 713-21.
5. Kalra VK, Ying Y, Deemer K, Natarajan R, Nadler JL, Coates TD. Mechanism of cigarette smoke condensate induced adhesion of human monocytes to cultured endothelial cells. J Cell Physiol 1994; 160: 154-62.
6. Shen Y, Rattan V, Sultana C, Kalra VK. Cigarette smoke condensate-induced adhesion molecule expression and transendothelial migration of monocytes. Am J Physiol 1996; 270: H1624-33.
7. Lehr HA, Frei B, Arfors KE. Vitamin C prevents cigarette smoke-induced leukocyte aggregation and adhesion to endothelium in vivo. Proc Natl Acad Sci USA 1994; 91: 7688-92.
8. Weiss SJ. Tissue destruction by neutrophils. New Engl J Med 1989; 320: 365-76.
9. van de Stolpe A, van der Saag PT. Intercellular adhesion molecule-1. J Mol Med 1996; 74: 13-33.
10. Adams MR, Jessup W, Celermajer DS. Cigarette smoking is associated with increased human monocyte adhesion to endothelial cells: reversibility with oral L-arginine but not vitamin C. J Am Coll Cardiol 1997; 29: 491-7.
11. Schaberg T, Rau M, Oerter R, Liebers U, Rahn W, Kaiser D et al. Expression of adhesion molecules in peripheral pulmonary vessels from smokers and nonsmokers. Lung 1996; 174: 71-81.
12. Rothlein R, Mainolfi EA, Czajkowski M, Marlin SD. A form of circulating ICAM-1 in human serum. J Immunol 1991; 147: 3788-93.
13. Bergmann S, Siekmeier R, Mix C, Jaross W. Even moderate cigarette smoking influences the pattern of circulating monocytes and the concentration of sICAM-1. Respiration Physiol 1998; 114: 269-75.
14. Blann AD, Seigneur M, Steiner M, Miller JP, McCollum CN. Circulating ICAM-1 and VCAM-1 in peripheral artery disease and hypercholesterolaemia: relationship to the location of atherosclerotic disease, smoking, and in the prediction of adverse events. Thrombosis Haemostasis 1998; 79: 1080-5.
15. Koundouros E, Odell E, Coward PY, Wilson RF, Palmer RM. Soluble adhesion molecules in serum of smokers and non-smokers, with and without periodontitis. J Periodont Res 1996; 31: 596-9.
16. Scott DA, Todd DH, Wilson RF, Coward PY, Odell EW, Poston RN et al. The acute influence of tobacco smoking on adhesion molecule expression on monocytes and neutrophils and on circulating adhesion molecule levels in vivo. Addiction Biology 2000; 5: 193-203.
17. Scott DA, Stapleton JA, Coward PY, Wilson RF, Sutherland G, Palmer RM et al. Dramatic decline in circulating intercellular adhesion molecule-1 concentrations on quitting smoking. Blood Cells Mol Dis 2000; 26: 255-8.
18. Scott DA, Palmer RM. The influence of tobacco smoking on adhesion molecule profiles. Tobacco Induced Dis 2002; 1: 7-25.
19. Palmer RM, Stapleton JA, Sutherland G, Coward PY, Wilson RP, Scott DA. Effect of nicotine replacement and quitting smoking on circulating adhesion molecule profiles (sICAM-1, sCD44v5, sCD44v6). Eur J Clin Invest 2002; 32: 852-7.
20. Crook MA, Scott DA, Stapleton JA, Palmer RM, Wilson RF, Sutherland G.Circulating concentrations of C-reactive protein and total sialic acid in tobacco smokers remain unchanged following one year of validated smoking cessation. Eur J Clin Invest 2000; 30: 861-5.
21. Barnett CC, Moore EE, Moore FA, Biffl WL, Partrick DA. Soluble intercellullar adhesion molecule-1 provokes polymorphonuclear leucocyte elastase release by CD18. Surgery 1996; 120: 395-402.
22. Barnett CC, Moore EE, Mierau GW, Partrick DA, Biffl WE, Elzi DJ et al. ICAM-1-CD18 interaction mediates neutrophil cytotoxicity through protease release. Am J Physiol 1998; 274: C1634-44.
23. Rieckmann P, Michel U, Albrecht M, Bruck W, Wockel L, Felgenhauer K. Soluble forms of intercellular adhesion molecule-1 (ICAM-1) block lymphocyte attachment to cerebral endothelial cells. J Neuroimmunol 1995; 60: 9-15.
24. Schmal H, Czermak BJ, Lentsch AB, Bless NM, Beck-Schimmer B, Friedl HP et al. Soluble ICAM-1 activates lung macrophages and enhances lung injury. J Immunol 1998; 161: 3685-93.
25. Spark JI, Scott DJA, Chetter IC, Guillou PJ, Kester RC. Does soluble intercellular adhesion molecule-1 (ICAM-1) affect neutrophil activation and adhesion following ischaemia-reperfusion? Eur J Vase Endovasc Surgery 1999; 17: 115-20.
26. Gho YS, Kim PN, Li HC, Elkin M, Kleinman HK. Stimulation of tumor growth by human soluble intercellular adhesion molecule-1. Cancer Res 2001; 61: 4253-7.
27. Gho YS, Kleinman HK, Sosne G. Angiogenic activity of human soluble intercellular adhesion molecule-1. Cancer Res 1999; 59: 5128-32.
28. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 1998; 351 (9096): 88-92.
29. Luc G, Arveiler D, Evans A, Amouyel P, Ferrieres J, Bard JM et al. Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and incident coronary heart disease: the PRIME Study. Atherosclerosis 2003; 170: 169-76.
30. Brevetti G, Piscione F, Silvestro A, Galasso G, Di Donato A, Oliva G et al. Increased inflammatory status and higher prevalence of three-vessel coronary artery disease in patients with concomitant coronary and peripheral atherosclerosis. Thromb Haemost 2003; 89: 1058-63.
31. Bongard V, Elias A, Bal dit Sollier C, Ruidavets J, Boccalon H, Drouet L et al. Soluble intercellular adhesion molecule-1 is associated with carotid and femoral atherosclerosis but not with intima-media thickness in a population-based sample. Atherosclerosis 2002; 164: 297-304.
32. Blankenberg S, Barbaux S, Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 2003; 170: 191-203.
33. Hillis GS, Pearson CV, Harding SA, Sutherland S, Ludlam CA, Marioni JC et al. Effects of a brief course of azithromycin on soluble cell adhesion molecules and markers of inflammation in survivors of an acute coronary syndrome: A double-blind, randomized, placebo-controlled study. Am Heart J 2004; 148: 72-9.
34. Leone M, Boutiere-Albanese B, Valette S, Camoin-Jau L, Barrau K, Albanese J et al. Cell adhesion molecules as a marker reflecting the reduction of endothelial activation induced by glucocorticoids. Shock 2004; 21: 311-4.
35. Sultan S, Gosling M, Nagase H, Powell JT. Shear stress-induced shedding of soluble intercellular adhesion molecule-1 from saphenous vein endothelium. FEBS Lett 200423; 564: 161-5.
36. 1-proteinase inhibitor by gas-phase cigarette smoke. Adv Free Biol Med 1986; 2: 161-88.
37. Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci USA 1989; 86: 6377-81.
38. Halliwell B, Gutteridge JMC. The antioxidants of human extracellular fluids. Arch Biochem Biophys 1990; 280: 1-8.
39. Eiserich JP, van der Vliet A, Handelman GJ, Halliwell B, Cross CE. Dietary antioxidants and cigarette smoke-induced biomolecular damage: a complex interaction. Am J Clin Nutr 1995; 62: 1490S-500S.
40. Handelman GJ, Packer L, Cross CE. Destruction of tocopherols, carotenoids, and retinol in human plasma by cigarette smoke. Am J Clin Nutr 1996; 63: 559-65.
41. Faruque MO, Khan MR, Rahman MM, Ahmed F. Relationship between smoking and antioxidant nutrient status. Brit J Nutr 1995; 73: 625-326.
42. Lykkesfeldt J, Loft S, Nielsen JB, Poulsen HE. Ascorbic acid and dehydroascorbic acid as biomarkers of oxidative stress caused by smoking. Am J Clin Nutr 1997; 65: 959-63.
43. Motoyama T, Kawano H, Kugiyama K, Hirashima O, Ohgushi M, Yoshimura M et al. Endothelium-dependent vasodilation in the brachial artery is impaired in smokers: effect of vitamin C. Am J Physiol 1997; 273: H1644-50.
44. Tribble DL, Giuliano LJ, Fortmann SP. Reduced plasma ascorbic acid concentrations in nonsmokers regularly exposed to environmental tobacco smoke. Am J Clin Nutr 1993; 58: 886-90.
45. Marangon K, Herbeth B, Lecomte E, Paul-Dauphin A, Grolier P, Chancerelle Y et al. Diet, antioxidant status, and smoking habits in French men. Am J Clin Nutr 1998; 67: 231-9.
46. Winklhofer-Roob BM, Ellemunter H, Fruhwirth M, Schlegel-Haueter SE, Khoschsorur G, van't Hof MA et al. Plasma vitamin C concentrations in patients with cystic fibrosis: evidence of associations with lung inflammation. Am J Clin Nutr 1997; 65: 1858-66.
47. Jones AM, Martin L, Bright-Thomas RJ, Dodd ME, McDowell A, Moffitt KL et al. Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa. Eur Respir J 2003; 22: 503-6.
48. Belo L, Santos-Silva A, Caslake M, Cooney J, Pereira-Leite L, Quintanilha A et al. Neutrophil activation and C-reactive protein concentration in preeclampsia. Hypertens Pregnancy 2003; 22: 129-41.
49. Karahan SC, Deger O, Orem A, Ucar F, Erem C, Alver A et al. The effects of impaired trace element status on polymorphonuclear leukocyte activation in the development of vascular complications in type 2 diabetes mellitus. Clin Chem Lab Med. 2001; 39: 109-15.
50. Lard LR, Mul FP, de Haas M, Roos D, Duits AJ. Neutrophil activation in sickle cell disease. J Leukoc Biol 1999; 66: 411-5.
51. Hind CRK, Joyce H, Tennent GA, Pepys MB, Pride NB. Plasma leucocyte elastase concentrations in smokers. J Clin Pathol 1991; 44: 232-5.
52. Tanaka T, Nakamura Y, Nasuno A, Mezaki T, Higuchi K, Fukunaga H et al. Plasma concentrations of monocyte chemoattractant protein 1 (MCP-1) and neopterin in the coronary circulation of patients with coronary artery disease. Circ J 2004; 68: 114-20.
53. Berdowska A, Zwirska-Korczala K. Neopterin measurement in clinical diagnosis. J Clin Pharm Ther 2001; 26: 319-29.
54. Werner ER, Bichler A, Daxenbichler G, Fuchs D, Fuith LC, Hausen A et al. Determination of neopterin in serum and urine. Clin Chem 1987; 33: 62-6
55. Huber C, Batchelor JR, Fuchs D, Hausen A, Lang A, Niederwieser D et al. Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J Exp Med 1984; 160: 310-6.
56. Birk D, Gansauge F, Gansauge S, Schwarz A, Beger HG. Levels of serum neopterin. Eur J Med Res 1999; 4: 156-60.
57. Walter RB, Fuchs D, Weiss G, Walter TR, Reinhart WH. HMG-CoA reductase inhibitors are associated with decreased serum neopterin levels in stable coronary artery disease. Clin Chem Lab Med 2003; 41: 1314-9.
58. Harper J, Cook R, McLaughlin B, McLaughlin BJ, Powers JC. Active site mapping of the serine pro teases: human leukocyte elastase, cathepsin G, porcine pancreatic elastase, rat mast cell proteases I and II using tripeptide thiobenzyl substrates. Biochem 1984; 23: 2995-3002.
59. Alavi AL, Palmer RM, Odell EW, Coward PY, Wilson RF. Elastase in gingival crevicular fluid from smokers and non-smokers with chronic inflammatory periodontal disease. Oral Dis 1995; 1: 103-5.
60. Feyerabend C, Russell MA. A rapid gas-liquid chromatographic method for the determination of cotinine and nicotine in biological fluids. J Pharm Pharmacol 1990; 42: 450-2.
61. Cominacini L, Garbin U, Pasini AF, Davoli A, Campagnola M, Contessi GB et al. Antioxidants inhibit the expression of intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 induced by oxidized LDL on human umbilical vein endothelial cells. Free Rad Biol Med 1997; 22: 117-27.
62. Weber C, Erl W, Weber K, Weber PC. Increased adhesiveness of isolated monocytes to endothelium is prevented by vitamin C intake in smokers. Circulation 1996; 93: 1488-92.
63. Mo SJ, Son EW, Rhee DK, Pyo S. Modulation of TNF-alpha-induced ICAM-1 expression, NO and H2O2 production by alginate, allicin and ascorbic acid in human endothelial cells. Arch Pharm Res 2003; 26: 244-51.
64. Rayment SJ, Shaw J, Woollard KJ, Lunec J, Griffiths HR. Vitamin C supplementation in normal subjects reduces constitutive ICAM-1 expression. Biochem Biophys Res Commun 2003; 308: 339-45.
65. Tousoulis D, Antoniades C, Tentolouris C, Tsioufis C, Toutouza M, Toutouzas P et al. Effects of combined administration of vitamins C and E on reactive hyperemia and inflammatory process in chronic smokers. Atherosclerosis 2003; 170: 261-7.
66. Scott DA, Palmer RM, Stapleton JA. Validation of smoking status in clinical research into inflammatory periodontal disease. J Clin Periodontol 2001; 28: 715-22.
67. Van Hoydonck PG, Schouten EG, Manuel-Y-Keenoy B, Van Campenhout A, Hoppenbrouwers KP, Temme EH. Does vitamin C supplementation influence the levels of circulating oxidized LDL, sICAM-1, sVCAM-1 and vWF-antigen in healthy male smokers? Eur J Clin Nutr 2004; 58: 1587-93.
68. Champagne B, Tremblay P, Cantin A, St Pierre Y. Proteolytic cleavage of ICAM-1 by human neutrophil elastase. J Immunol 1998; 161: 6398-405.
69. Stone PJ, Gottlieb DJ, O'Connor GT, Ciccolella DE, Breuer R, Bryan-Rhadfi J et al. Elastin and collagen degradation products in urine of smokers with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 151: 952-9.
70. Seow WK, Thong YH, Nelson RD, MacFarlane GD, Herzberg MC. Nicotine-induced release of elastase and eicosanoids by human neutrophils. Inflammation 1994; 18: 119-27.